Female Viagra contender Palatin Technologies explores potential sale: Reuters

Palatin Technologies Inc (PTN.A), which is looking to take the throne from Addyi as the primary drug treatment for low sex drive in women, has hired an investment bank to explore a sale or licensing deal, a source told Reuters.

DealsNorth AmericaUSBriefs